Pre-clinical Trials Completed

We are thrilled to share a momentous achievement in our ongoing journey to transform wound closure with Sutrips.

In our recent independent clinical trial, Sutrips underwent test against the conventional interrupted suture technique.

The results speak volumes, and we couldn’t be more excited to reveal our progress!

This milestone takes us one step closer to realizing our mission: making wound closure universally accessible, affordable, and efficient.

For those eager to delve deeper into the clinical trial findings, we invite you to explore the full report, available for download. Please Click here.

Stay tuned as we continue to pioneer innovation in wound closure for a healthier world.

Ubbat Ocak

Ubbat Ocak is a visionary entrepreneur and the driving force behind MUB Medical Solutions. With a passion for innovation and a deep understanding of the healthcare industry, Ubbat has dedicated himself to revolutionizing wound closure practices. His relentless pursuit of excellence and commitment to making a positive impact have propelled MUB Medical to the forefront of the field. Ubbat's leadership and forward-thinking approach inspire his team to push boundaries and deliver cutting-edge solutions that improve patient outcomes. With his unwavering determination and strategic vision, Ubbat Ocak is shaping the future of wound closure technologies.